Bluejay Diagnostics (BJDX) Accumulated Expenses (2020 - 2026)

Bluejay Diagnostics has reported Accumulated Expenses for 7 years, with the latest figure at $1.1 million in Q1 2026.

• Quarterly Accumulated Expenses rose 506.22% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 506.22% YoY) and the FY2025 annual result came in at $804942.0, up 45.83% from the prior year.
• Accumulated Expenses grew to $1.1 million in Q1 2026 per BJDX's latest filing, from $804942.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $1.9 million in Q3 2023 and troughed at $143449.0 in Q3 2024.
• A 5-year average of $832089.9 and a median of $835730.0 in 2022 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2026: Accumulated Expenses slumped 92.35% in 2024, then jumped 506.22% in 2026.
• Over 5 years, Accumulated Expenses stood at $835730.0 in 2022, then soared by 33.64% to $1.1 million in 2023, then sank by 50.58% to $551986.0 in 2024, then surged by 45.83% to $804942.0 in 2025, then soared by 36.23% to $1.1 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $1.1 million, $804942.0, and $264513.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.